Artiva Biotherapeutics, Inc. ARTV
- AlloNK — Rheumatoid Arthritis Phase 2
- AlloNK — Sjögren's Disease Phase 2
- AlloNK — Systemic Sclerosis Phase 2
CD16 (1 companies · 3 programs)
Companies with an active program directed at CD16.
Companies with an active program directed at CD16.